| Financial Year |
March 31 2023 |
| Monetary Funds |
564,560,805.44 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
102,423,309.52 |
| Accounts Receivable |
332,831,296.58 |
| Advances to Suppliers |
9,429,639.74 |
| Other Receivables |
5,502,216.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
319,767,492.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
1,341,462,599.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
145,726,095.70 |
| Under-construction Projects |
8,754,016.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,706,412.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,454,557.22 |
| Other Non-Current Assets |
10,833,597.55 |
| Sub-Total of Non-Current Assets |
201,131,968.48 |
| Total Assets |
1,542,594,568.47 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
57,501,099.08 |
| Accounts Payable |
121,809,777.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,967,827.76 |
| Taxes Payable |
8,106,498.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
475,926.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
323,520.86 |
| Other Current Liabilities |
42,252,573.29 |
| Sub-Total of Current Liabilities |
257,810,905.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,013,169.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,285,211.93 |
| Total Liabilities |
268,096,116.94 |
| Paid-In Capital(Or Share Stock) |
150,370,510.00 |
| Capital Surplus |
858,506,191.23 |
| Surplus Reserve |
31,498,445.21 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
237,700,842.29 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,274,498,451.53 |
| Owner's Equity（Stockholder's Equity） |
1,274,498,451.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,542,594,568.47 |
